SK282543B6 - Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe - Google Patents

Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe Download PDF

Info

Publication number
SK282543B6
SK282543B6 SK1359-95A SK135995A SK282543B6 SK 282543 B6 SK282543 B6 SK 282543B6 SK 135995 A SK135995 A SK 135995A SK 282543 B6 SK282543 B6 SK 282543B6
Authority
SK
Slovakia
Prior art keywords
hcv
epitopes
polypeptides
type
epitope
Prior art date
Application number
SK1359-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK135995A3 (en
Inventor
David Y. Chien
George Kuo
Original Assignee
Chiron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22029220&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282543(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corporation filed Critical Chiron Corporation
Publication of SK135995A3 publication Critical patent/SK135995A3/sk
Publication of SK282543B6 publication Critical patent/SK282543B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1359-95A 1993-05-10 1994-05-09 Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe SK282543B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6040093A 1993-05-10 1993-05-10
PCT/US1994/005151 WO1994027153A1 (en) 1993-05-10 1994-05-09 Methods of typing hepatitis c virus and reagents for use therein

Publications (2)

Publication Number Publication Date
SK135995A3 SK135995A3 (en) 1996-09-04
SK282543B6 true SK282543B6 (sk) 2002-10-08

Family

ID=22029220

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1359-95A SK282543B6 (sk) 1993-05-10 1994-05-09 Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe

Country Status (19)

Country Link
US (3) US6054264A (pl)
EP (1) EP0698216B2 (pl)
JP (1) JP3645904B2 (pl)
KR (1) KR100330278B1 (pl)
CN (1) CN1129795C (pl)
AT (1) ATE281647T1 (pl)
CZ (1) CZ294629B6 (pl)
DE (1) DE69434117T3 (pl)
DK (1) DK0698216T4 (pl)
ES (1) ES2232815T5 (pl)
GE (1) GEP20012421B (pl)
HU (1) HU224513B1 (pl)
PL (3) PL175338B1 (pl)
PT (1) PT698216E (pl)
RO (1) RO115471B1 (pl)
RU (1) RU2158928C2 (pl)
SK (1) SK282543B6 (pl)
UA (1) UA46707C2 (pl)
WO (1) WO1994027153A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671967B2 (en) * 1991-11-21 1996-09-19 Common Services Agency Hepatitis-C virus testing
US7255997B1 (en) * 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
ATE553201T1 (de) 1993-04-27 2012-04-15 Innogenetics Nv Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel
CZ294629B6 (cs) * 1993-05-10 2005-02-16 Chiron Corporation Způsob klasifikace typů hepatitis C viru, polypeptid a kompozice pro použití ve způsobu
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
EP0829488A4 (en) * 1995-04-28 1999-04-07 Srl Inc ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
US8124348B2 (en) 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
CA2481502A1 (en) * 2002-04-04 2003-10-16 Achillion Pharmaceuticals, Inc. Hcv antiviral and cytotoxicity drug screening assay
WO2005010035A2 (en) * 2003-07-22 2005-02-03 Branch Andrea D Alternate reading frame polypeptides derived from hepatitis c and methods of their use
EP1658302B1 (en) * 2003-07-25 2010-08-25 IDENIX Pharmaceuticals, Inc. Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
ES2596753T3 (es) * 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
JP5138230B2 (ja) 2004-01-07 2013-02-06 サード・ウェーブ・テクノロジーズ・インク Ｃ型肝炎ウイルスの遺伝子型の決定方法
JP4533656B2 (ja) * 2004-04-28 2010-09-01 アボットジャパン株式会社 特異性の改良されたｃ型肝炎ウイルス（ｈｃｖ）抗体測定法
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
DE3886363T3 (de) * 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR100206150B1 (ko) * 1990-04-04 1999-07-01 로버트 피. 블랙버언 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
US6190864B1 (en) * 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
UA40572C2 (uk) * 1991-06-24 2001-08-15 Чірон Корпорейшн Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
DE69223562T2 (de) * 1991-08-27 1998-06-04 Hoffmann La Roche Verfahren und Reagenzien zum Nachweis von Hepatitis C
EP0532258A2 (en) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
CA2119013A1 (en) * 1991-09-16 1993-04-01 Richard R. Lesniewski Hepatitis c assay
AU671967B2 (en) * 1991-11-21 1996-09-19 Common Services Agency Hepatitis-C virus testing
EP1878797B1 (en) 1992-07-16 2010-04-28 Advanced Life Science Institute, Inc Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
NZ257077A (en) * 1992-11-06 1997-05-26 Chiron Mimotopes Pty Ltd Support for synthesis of modular polymers
JP3751315B2 (ja) 1993-05-05 2006-03-01 コモン サーヴィシス エージェンシー Ｃ型肝炎ウイルス４、５及び６型
CZ294629B6 (cs) * 1993-05-10 2005-02-16 Chiron Corporation Způsob klasifikace typů hepatitis C viru, polypeptid a kompozice pro použití ve způsobu
EP0729973A4 (en) * 1993-10-29 1998-12-30 Srl Inc AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE

Also Published As

Publication number Publication date
GEP20012421B (en) 2001-04-25
JPH08510329A (ja) 1996-10-29
DE69434117T2 (de) 2006-02-02
HU224513B1 (hu) 2005-10-28
CN1125982A (zh) 1996-07-03
EP0698216A1 (en) 1996-02-28
CZ294629B6 (cs) 2005-02-16
JP3645904B2 (ja) 2005-05-11
UA46707C2 (uk) 2002-06-17
PL175338B1 (pl) 1998-12-31
US6054264A (en) 2000-04-25
PL311653A1 (en) 1996-03-04
DE69434117D1 (de) 2005-01-20
DK0698216T4 (da) 2009-06-15
US6416944B1 (en) 2002-07-09
PT698216E (pt) 2005-03-31
CZ292995A3 (en) 1996-05-15
ES2232815T3 (es) 2005-06-01
CN1129795C (zh) 2003-12-03
DE69434117T3 (de) 2009-10-08
PL175342B1 (pl) 1998-12-31
HUT73384A (en) 1996-07-29
ES2232815T5 (es) 2009-06-15
EP0698216B1 (en) 2004-11-03
ATE281647T1 (de) 2004-11-15
US6416946B1 (en) 2002-07-09
EP0698216B2 (en) 2009-02-25
HU9503219D0 (en) 1996-01-29
KR100330278B1 (ko) 2002-08-19
WO1994027153A1 (en) 1994-11-24
RU2158928C2 (ru) 2000-11-10
PL175360B1 (pl) 1998-12-31
SK135995A3 (en) 1996-09-04
DK0698216T3 (da) 2005-02-14
RO115471B1 (ro) 2000-02-28

Similar Documents

Publication Publication Date Title
SK282543B6 (sk) Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe
US7728121B2 (en) Hepatitis-C virus type 4, 5 and 6
FI113967B (fi) Hepatitis-C-virustesti
JP2007197456A (ja) Ｎａｎｂｖの診断用薬
Chang et al. Artificial NS4 mosaic antigen of hepatitis C virus
CA2162250C (en) Methods of typing hepatitis c virus and reagents for use therein
CA2162134C (en) Hepatitis-c virus type 4,5 and 6
PT89041B (pt) Metodo de preparacao de diagnosticos e vacinas nanbv

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20140509